This trial studies if medications that remove metals from the body can help patients with certain types of blood cancer respond better to chemotherapy. It focuses on patients with acute myeloid leukemia or myelodysplastic syndrome. The goal is to see if lowering metal levels can improve treatment outcomes. Iron chelation therapy has been shown to improve survival and quality of life in patients with myelodysplastic syndrome (MDS).